Study to improve PrEP use in primary care
Part of Immune system & allergy, Infections clinical trials.
This trial tests ways to help primary care providers and their patients start using PrEP, a daily pill that prevents HIV. It may be right for you if you are interested in HIV prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a primary care appointment at a Henry Ford clinic during the study.
- You have an online health record account (MyChart).
- You are not already taking PrEP.
- You do not have HIV.
- Your doctor thinks you could benefit from PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling program to help more people who could benefit from PrEP (a pill that prevents HIV) actually start taking it. If you're a healthcare provider or someone looking for HIV prevention, this study might help improve access to PrEP.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study helps pharmacies that do not yet offer PrEP (the daily medicine that prevents HIV) learn how to start. It provides training and support on the basics of PrEP and how to make it financially sustainable.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
Hear when a new HIV Seropositivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.